Skip to content

Therapeutic effect of blood purification combined with ß-hydroxy-ß-methylbutyric acid (HMB) on calcium and phosphorus metabolism disorder in uremic patients

Therapeutic effect of blood purification combined with ß-hydroxy-ß-methylbutyric acid (HMB) on calcium and phosphorus metabolism disorder in uremic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022420
Enrollment
Unknown
Registered
2019-04-10
Start date
2019-02-11
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

toxuria

Interventions

Experimental group:Add HMB
Control group:Blank

Sponsors

Chengdu Fifth people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of uremia formulated in the summary of the Huangshan conference in 1992, or the diagnostic criteria of the K/DOQI expert group of the American Kidney Disease Foundation for the diagnosis of CKD5 stage in (CKD) staging of chronic renal diseases; (2) maintenance of hemodialysis for more than 3 months; (3) there was no obvious organic lesion outside the kidney, such as liver, heart and other serious disorders; (4) Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. liver function, severe cardiac dysfunction; 2. parathyroid resection has been performed; 3. can not cooperate with the completion of the test; 4. this product and leucine allergies and people with high allergies.

Design outcomes

Primary

MeasureTime frame
Serum phosphorus;calcium serum;

Secondary

MeasureTime frame
parathormone;

Countries

China

Contacts

Public ContactWang Zhong

Chengdu Fifth People's Hospital

347005@qq.com+86 13388167079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026